Department of Pharmaceutical Chemistry, Institute of Health Sciences, Marmara University, Kartal, 34865 İstanbul, Turkey; Department of Analytical Development and Validation, Atabay Pharmaceuticals and Fine Chemicals Inc., Kadıköy, 34718 İstanbul, Turkey.
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Marmara University, Başıbüyük, 34854 İstanbul, Turkey.
J Pharm Biomed Anal. 2023 Jan 20;223:115123. doi: 10.1016/j.jpba.2022.115123. Epub 2022 Oct 26.
One of the impurities of acetaminophen, N,N'-(oxydi-4,1-phenylene)diacetamide (ODAA), which is not specified in the organic impurities analysis method of acetaminophen by high performance liquid chromatography (HPLC) in American Pharmacopoeia Version 42 (USP 42), was synthesized, characterized and standardized. A new and optimized liquid chromatographic method for the determination of organic impurities of acetaminophen was developed using an ultra-high performance liquid chromatographic (UHPLC) system, which can separate this impurity. This new liquid chromatographic method has been optimized and validated for the simultaneous determination of acetaminophen related compound B, acetaminophen related compound C, acetaminophen related compound D, acetaminophen related compound J and ODAA, the organic impurities in acetaminophen drug substance. Acetaminophen was also subjected to stress-testing under acidic hydrolysis, alkaline hydrolysis, oxidative degradation, thermal degradation and photolytic degradation for 15 days. The impurity molecule, ODAA was synthesized using 4,4'-oxydianiline and acetic anhydride. The chemical structure of the synthesized ODAA molecule was confirmed by characterization studies. The potency of ODAA was found to be 99.64% as a result of the relevant analyses. The chromatographic separation was achieved on a C8 (150 mm × 2.1 mm; 2-µm particle size) reversed-phase column using a gradient elution, being solvent A: methanol-water-glacial acetic acid (50:950:1, v/v/v) and solvent B: methanol-water-glacial acetic acid (500:500:1, v/v/v) flowing at a rate of 0.2 mL/min. The limits of quantitation (S/N 10:1) were 1.248 µg/mL for acetaminophen, 0.373 µg/mL for acetaminophen related compound B, 1.217 µg/mL for acetaminophen related compound C, 0.369 µg/mL for acetaminophen related compound D, 0.125 µg/mL for acetaminophen related compound J and 0.373 µg/mL for ODAA. The individual mean recoveries of each impurity molecule spiked into acetaminophen samples at different concentration levels ranged from 93% to 104%. The method developed for UHPLC instrument was successfully applied to the analyses of different lots of acetaminophen. Thus, the proposed method can be used for determination of this impurity in the presence of other specified impurities of acetaminophen.
对醋氨酚中一种杂质 N,N'-(氧代-4,1-亚苯基)二乙酰胺(ODAA)进行了合成、表征和标准化,该杂质在美国药典 42 版(USP 42)中规定的醋氨酚高效液相色谱(HPLC)有机杂质分析方法中未明确规定。开发了一种新的优化的超高效液相色谱(UHPLC)系统用于测定醋氨酚的有机杂质,该方法可以分离出该杂质。该新的液相色谱方法已针对醋氨酚相关化合物 B、醋氨酚相关化合物 C、醋氨酚相关化合物 D、醋氨酚相关化合物 J 和 ODAA 的同时测定进行了优化和验证,这些都是醋氨酚原料药中的有机杂质。醋氨酚还在酸性水解、碱性水解、氧化降解、热降解和光降解条件下进行了 15 天的稳定性测试。ODAA 杂质分子是使用 4,4'-氧二苯胺和乙酸酐合成的。通过特征研究确认了合成的 ODAA 分子的化学结构。相关分析结果表明 ODAA 的效价为 99.64%。在 C8(150mm×2.1mm;2µm 粒径)反相柱上,采用梯度洗脱,流动相 A:甲醇-水-冰醋酸(50:950:1,v/v/v)和流动相 B:甲醇-水-冰醋酸(500:500:1,v/v/v),流速为 0.2mL/min,实现了色谱分离。定量限(S/N 10:1)分别为 1.248µg/mL 对醋氨酚、0.373µg/mL 对醋氨酚相关化合物 B、1.217µg/mL 对醋氨酚相关化合物 C、0.369µg/mL 对醋氨酚相关化合物 D、0.125µg/mL 对醋氨酚相关化合物 J 和 0.373µg/mL 对 ODAA。不同浓度水平下将各杂质分子加入醋氨酚样品中的单个平均回收率在 93%至 104%之间。为 UHPLC 仪器开发的方法成功应用于不同批次的醋氨酚分析。因此,该方法可用于在存在其他规定的醋氨酚杂质的情况下测定该杂质。